These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34543531)

  • 1. Clinical and prognostic significance of the soluble form of the VISTA immunity control point in patients with primary bone tumors.
    Kushlinskii NE; Kovaleva OV; Kuzmin YB; Korotkova EA; Gershtein ES; Boulytcheva IV; Kozlova EV; Kudlay DA; Podlesnaya PA; Gratchev AN; Kuznetsov IN; Sushentsov EA
    Klin Lab Diagn; 2021 Sep; 66(9):533-538. PubMed ID: 34543531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of the levels of soluble forms of receptor and ligand of the immunity control point PD-1/PD-L1 in the blood serum of patients with typical bone osteosarcoma and chondrosarcoma.
    Kushlinskii NE; Alferov AA; Boulytcheva IV; Timofeev YS; Korotkova EA; Khvan OT; Kuzmin YB; Kuznetsov IN; Bondarev AV; Shchupak MY; Sokolov NY; Efimova MM; Gershtein ES; Sushentsov EA; Aliev MD; Musaev ER
    Klin Lab Diagn; 2020 Dec; 65(11):669-675. PubMed ID: 33301655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key Immune Checkpoint PD-1/PD-L1 Signaling Pathway Components in the Blood Serum from Patients with Bone Tumors.
    Kushlinskii NE; Alferov AA; Timofeev YS; Gershtein ES; Bulycheva IV; Bondarev AV; Shchupak MY; Sokolov NY; Polikarpova SB; Efimova MM; Dzampaev AA; Sushentsov EA; Aliev MD; Musaev ER
    Bull Exp Biol Med; 2020 Nov; 170(1):64-68. PubMed ID: 33231796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. sCD30 and sCD40L detection in patients with osteosarcoma, chondrosarcoma and Ewing sarcoma.
    Solooki S; Khozaei A; Shamsdin SA; Emami MJ; Khademolhosseini F
    Iran J Immunol; 2013 Dec; 10(4):229-37. PubMed ID: 24375064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic and survival trends in adult primary bone tumors of the spine.
    Kerr DL; Dial BL; Lazarides AL; Catanzano AA; Lane WO; Blazer DG; Brigman BE; Mendoza-Lattes S; Eward WC; Erickson ME
    Spine J; 2019 Dec; 19(12):1941-1949. PubMed ID: 31306757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteosarcoma, Chondrosarcoma, and Chordoma.
    Whelan JS; Davis LE
    J Clin Oncol; 2018 Jan; 36(2):188-193. PubMed ID: 29220289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of extent of local tumor invasion and survival in patients with malignant primary osseous spinal neoplasms from the surveillance, epidemiology, and end results (SEER) database.
    Mukherjee D; Chaichana KL; Adogwa O; Gokaslan Z; Aaronson O; Cheng JS; McGirt MJ
    World Neurosurg; 2011 Dec; 76(6):580-5. PubMed ID: 22251507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor Activator of Nuclear Transcription Factor NF-κB (RANK), Its Ligand RANKL, and Natural Inhibitor of RANKL Osteoprotegerin (OPG) in the Blood Serum of Patients with Primary Bone Tumors.
    Kushlinskii NE; Gershtein ES; Solov'ev YN; Timofeev YS; Babkina IV; Dolinkin AO; Zuev AA; Kostyleva OI
    Bull Exp Biol Med; 2017 Aug; 163(4):478-481. PubMed ID: 28853064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
    Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
    Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Components of the RANK/RANKL/OPG system, IL-6, IL-8, IL-16, MMP-2, and calcitonin in the sera of patients with bone tumors.
    Kushlinskii NE; Timofeev YS; Solov'ev YN; Gerstein ES; Lyubimova NV; Bulycheva IV
    Bull Exp Biol Med; 2014 Aug; 157(4):520-3. PubMed ID: 25110097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locally challenging osteo- and chondrogenic tumors of the axial skeleton: results of combined proton and photon radiation therapy using three-dimensional treatment planning.
    Hug EB; Fitzek MM; Liebsch NJ; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):467-76. PubMed ID: 7852108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APPARENTLY SOLITARY TUMORS OF THE VERTEBRAL COLUMN.
    COHEN DM; DAHLIN DC; MACCARTY CS
    Mayo Clin Proc; 1964 Jul; 39():509-28. PubMed ID: 14163176
    [No Abstract]   [Full Text] [Related]  

  • 14. [Primary malignant skeletal tumors].
    Semb H
    Lakartidningen; 1972 Jan; 69(3):247-52. PubMed ID: 4552489
    [No Abstract]   [Full Text] [Related]  

  • 15. Gamma Knife surgery for intracranial chordoma and chondrosarcoma: radiosurgical perspectives and treatment outcomes.
    Kim JH; Jung HH; Chang JH; Chang JW; Park YG; Chang WS
    J Neurosurg; 2014 Dec; 121 Suppl():188-97. PubMed ID: 25434952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electron microscopy of bone tumors--osteosarcoma, chondrosarcoma, giant cell tumor of bone.
    Komiya S
    Nihon Seikeigeka Gakkai Zasshi; 1982 Jul; 56(7):635-57. PubMed ID: 6960100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SPINAL NEOPLASMS. II. MALIGNANT NEOPLASMS OF THE SPINE].
    CERVENANSKY J
    Bratisl Lek Listy; 1963; 43():408-23. PubMed ID: 14058891
    [No Abstract]   [Full Text] [Related]  

  • 18. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
    Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
    World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antibodies against the heat shock protein 60 are elevated in patients with osteosarcoma.
    Trieb K; Gerth R; Windhager R; Grohs JG; Holzer G; Berger P; Kotz R
    Immunobiology; 2000 Jan; 201(3-4):368-76. PubMed ID: 10776793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations of sCD30 and sCD40L in patients with malignant bone tumours.
    Holzer G; Pfandlsteiner T; Blahovec H; Trieb K; Kotz R
    Wien Med Wochenschr; 2003; 153(1-2):40-2. PubMed ID: 12621691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.